Aspiriant, LLC
About Aspiriant, LLC’s 13F portfolio
Aspiriant, LLC is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Aspiriant, LLC reported $4.1B across 400 US-listed positions (). Its largest position is ISHARES TR (IVV) at 16% of the reported book, and its ten biggest holdings make up 64% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NYSE Arca: IVV ISHARES TR | — — | 16% | 861K | $644.5M |
| 2 | NYSE Arca: VBR VANGUARD INDEX FDS | — — | 10% | 1.7M | $424.2M |
| 3 | NASDAQ: IUSV ISHARES TR | — — | 10% | 3.7M | $406.0M |
| 4 | Cboe BZX: ACWV ISHARES INC | — — | 7.2% | 2.4M | $292.5M |
| 5 | NYSE Arca: VIG VANGUARD SPECIALIZED FUNDS | — — | 5.6% | 955K | $226.0M |
| 6 | NYSE Arca: VTEB VANGUARD MUN BD FDS | — — | 5.3% | 4.3M | $216.1M |
| 7 | NYSE Arca: VOO VANGUARD INDEX FDS | — — | 3.1% | 181K | $124.5M |
| 8 | Cboe BZX: IEFA ISHARES TR | — — | 2.4% | 1.0M | $97.6M |
| 9 | NYSE Arca: IEMG ISHARES INC | — — | 2.2% | 1.1M | $88.5M |
| 10 | Cboe BZX: EFV ISHARES TR | — — | 2.0% | 1.1M | $81.2M |
| 11 | NASDAQ: AAPL APPLE INC | — — | 2.0% | 278K | $80.5M |
| 12 | NYSE Arca: IWB ISHARES TR | — — | 1.2% | 116K | $47.5M |
| 13 | NYSE Arca: SPY STATE STR SPDR S&P 500 ETF T | — — | 1.1% | 58K | $43.4M |
| 14 | NASDAQ: BND VANGUARD BD INDEX FDS | — — | 1.0% | 546K | $40.1M |
| 15 | NYSE Arca: DFUV DIMENSIONAL ETF TRUST | — — | 1.0% | 707K | $38.9M |
| 16 | NYSE Arca: VTI VANGUARD INDEX FDS | — — | 0.9% | 103K | $38.3M |
| 17 | NYSE Arca: FBND FIDELITY MERRIMACK STR TR | — — | 0.9% | 834K | $37.9M |
| 18 | BRK/B BERKSHIRE HATHAWAY INC DEL | — — | 0.9% | 73K | $36.5M |
| 19 | NYSE Arca: AOR ISHARES TR | — — | 0.9% | 515K | $35.8M |
| 20 | NYSE Arca: VIOV VANGUARD ADMIRAL FDS INC | — — | 0.9% | 296K | $34.7M |
| 21 | NYSE Arca: CRBN ISHARES TR | — — | 0.8% | 123K | $31.0M |
| 22 | NYSE Arca: MUB ISHARES TR | — — | 0.7% | 280K | $30.2M |
| 23 | NYSE Arca: VEU VANGUARD INTL EQUITY INDEX F | — — | 0.7% | 332K | $27.8M |
| 24 | NYSE Arca: VB VANGUARD INDEX FDS | — — | 0.7% | 90K | $27.4M |
| 25 | NYSE Arca: DFAX DIMENSIONAL ETF TRUST | — — | 0.7% | 728K | $26.8M |
Showing 1–25 of 400 positions on this page reported in this 13F.
- Technology3.6%
- Financial Services1.9%
- Communication Services1.2%
- Healthcare0.7%
- Industrials0.7%
- Consumer Cyclical0.5%
- Consumer Defensive0.4%
- Energy0.3%
- Basic Materials0.2%
- Utilities0.1%
- Real Estate0.1%
- AddedIVVISHARES TR+30.0%$644.5M
- AddedVBRVANGUARD INDEX FDS+0.3%$424.2M
- AddedIUSVISHARES TR+0.1%$406.0M
- AddedVTEBVANGUARD MUN BD FDS+0.9%$216.1M
- AddedVOOVANGUARD INDEX FDS+0.0%$124.5M
- AddedIEFAISHARES TR+2.4%$97.6M
- AddedAAPLAPPLE INC+2.4%$80.5M
- AddedIWBISHARES TR+3.0%$47.5M
- AddedBNDVANGUARD BD INDEX FDS+1.0%$40.1M
- AddedVTIVANGUARD INDEX FDS+9.6%$38.3M
- ReducedACWVISHARES INC−0.2%$292.5M
- ReducedVIGVANGUARD SPECIALIZED FUNDS−0.0%$226.0M
- ReducedIEMGISHARES INC−0.4%$88.5M
- ReducedEFVISHARES TR−0.8%$81.2M
- ReducedSPYSTATE STR SPDR S&P 500 ETF T−1.6%$43.4M
- ReducedDFUVDIMENSIONAL ETF TRUST−0.2%$38.9M
- ReducedBRK/BBERKSHIRE HATHAWAY INC DEL−1.5%$36.5M
- ReducedVIOVVANGUARD ADMIRAL FDS INC−3.5%$34.7M
- ReducedMUBISHARES TR−3.0%$30.2M
- ReducedVEUVANGUARD INTL EQUITY INDEX F−0.4%$27.8M
Reading Aspiriant, LLC’s 13F portfolio
Aspiriant, LLC’s $4.1B 13F book is spread across 400 reported positions and is highly concentrated — its ten largest positions alone are 64% of the portfolio. A book this concentrated means a small group of names drives most of its performance. Its five largest positions are IVV, VBR, IUSV, ACWV and VIG, led by ISHARES TR (IVV) at 16% of the portfolio. The heaviest sector exposure is Technology (4%), then Financial Services (2%).
What Aspiriant, LLC changed last quarter
Between 2026-03-31 and Q2 2026, Aspiriant, LLC was a net buyer: it opened 76 new positions and added to 190 more, while trimming 81 and closing 14 outright. Against a 400-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was ISHARES TR (IVV), and its biggest reduction was ISHARES INC (ACWV).
What a 13F does and doesn’t reveal
A 13F captures only Aspiriant, LLC’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Aspiriant, LLC is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Aspiriant, LLC's profile on this page is built directly from those filings.
How current is the 13F data on Aspiriant, LLC's page?
It reflects Aspiriant, LLC's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Aspiriant, LLC files its next quarterly report, this page refreshes automatically.
Can I see Aspiriant, LLC's complete list of holdings?
This page highlights Aspiriant, LLC's largest positions rather than all 400 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Aspiriant, LLC's filings.
Does a 13F show everything Aspiriant, LLC owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Aspiriant, LLC's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Aspiriant, LLC made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

